You are here: Home » Markets » IPOS » News
Business Standard

The drought for India's IPOs may be easing in their worst year since 2016

A bunch of firms -- ranging from a drugmaker to a jeweler -- will likely test investor demand over the next few months, helping revive fundraising through first-time sales from the lowest in 4 years

IPOs | Investors

Nupur Acharya Julia Fioretti & Baiju Kalesh | Bloomberg 

Illustration: Ajay Mohanty

A drought in India’s initial public offerings might be easing with companies preparing to tap a buoyant stock market after piled into two recent sales.

A bunch of firms -- ranging from a drugmaker to a jeweler -- will likely test investor demand over the next few months, helping revive fundraising through first-time sales from the lowest in four years.

While Hong Kong and China have seen a flurry of new listings amid abundant liquidity, activity in India is seen picking up after from Happiest Minds Technology Ltd. and Route Mobile Ltd. last week lured hordes of keen to bet on companies expected to gain from rapid adoption of digital services.

“The primary market is a preferred way to play new ideas and that is why there is a rush for public offers,” said Mangesh Ghogre, executive director and the head of equity capital at Nomura India. “believe there’s upside in the primary market.”

That belief prompted investors to bid for Happiest Minds 151 times over, making it one of India’s most successful of this decade. Route Mobile, a cloud infrastructure provider, was oversubscribed 73 times. The sales are a bright spot in a market that’s seen little over $2 billion being raised from in 2020, the least for the period since 2016, despite the 50% jump in the main equity indexes from the March lows.

IPO chart

“There is ample liquidity globally and as funds, especially the long only ones who were sitting on record levels of cash and had mostly stayed out of the rally, are now chasing performance through equity deals,” Sunil Khaitan, India head, Global Capital at Bank of America, said in an email.

The IPO pipeline includes a spinoff of Gland Pharma Ltd. by Shanghai Fosun Pharmaceutical (Group) Co. that could raise as much as $800 million, according to people familiar with the matter. Kalyan Jewellers India Ltd., Computer Age Management Services, UTI Asset Management Co., Angel Broking Ltd. and the National Commodity and Derivatives Exchange Ltd. are also looking to list, according to PRIME Database.

“Investors are looking for exciting stories that have an edge and can capitalize on the current disruption,” said Amitabh Malhotra, head of investment banking at HSBC India. “We are seeing well-governed mid-cap companies come to the market across follow-on placements and IPOs.”

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, September 16 2020. 15:34 IST